Altimmune
ALT
ALT
25 hedge funds and large institutions have $1.32M invested in Altimmune in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
16% less capital invested
Capital invested by funds: $1.57M → $1.32M (-$248K)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
25
Holding in Top 10
1
Calls
–
Puts
$2K
Top Buyers
| 1 | +$575K | |
| 2 | +$153K | |
| 3 | +$30K | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$23.5K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$22K |
Top Sellers
| 1 | -$125K | |
| 2 | -$49K | |
| 3 | -$19K | |
| 4 |
BlackRock
New York
|
-$16.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$16.2K |